Data provision medicine shortages

Update March 2022

In order to enable a simple integration of current contents of the „Shortages catalogue“ into external IT systems, two endpoints are provided in a pilot operation. No authentication is required.

The underlying instructions for use are available at: https://www.basg.gv.at/fuer-unternehmen/online-service/nutzungshinweise

Endpoint public Internethttps://webservices.basg.gv.at/medicineshortage/export/v1/download
Endpoint GINhttps://webservices-ginet.basg.gv.at/medicineshortage/export/v1/download

General information

Since February 1, 2018, marketing authorisation holders and their authorised representatives have to submit medicine shortages electronically by using the application eService "Marketing Authorisation & Lifecycle Management of Medicines".

Medicine shortages are published on the „Shortages catalogue“ on the actual date of beginning of the shortage.

Marketing authorisation holders and their authorised representatives have to submit medicine shortages because of the regulation on ensuring the provision of medicinal products, that enters into force as from April 1, 2020, and because of the "Arzneimittelbetriebsordnung 2009". They are now obliged to report any restriction in supply of prescription-only human medicinal products using the eService.

The notification of a shortage affecting veterinary medicinal products and over-the-counter medicinal products is voluntary, if it is not subject to notification in accordance with the "Arzneimittelbetriebsordnung 2009".

Since December 10, 2020, the BASG has also been offering the contents of the "Shortages catalogue", including information on parallelexport bans, in machine-readable form (XML).

In principle, the data export contains all shortages notifications that are also displayed in the „Shortages catalogue“. Not included are those notifications for which a resupply date has already been entered by the distributor for all affected packages and this resupply date has already been reached.
This means that pack sizes of a reported proprietary medicinal product that are reported as "not available", "restricted availability", "available acc. to § 4 (1)" or "available" will be made available in the XML as long as the report has not been completed by reavailability of all packs concerned. Please pay attention to the respective status of the packages when processing the data.

To simplify the processing of the reports, the provision is grouped according to PIP codes.
A provision of REST-based API retrieval options is already being planned and is expected to be completed from Q2/2022.

Release Notes

The data file is created daily (between 0:00 and 4:00 am) and made available on the BASG website under "Data provision medicine shortages".

XML schema of the data provision

XML schema: Contents and description of the export data

Designation of the data contents

Description

File information 

producedOn

Day and timestamp of the creation of the export file

MD5sumMD5 sum of the packs. Used to identify changes
Pack size information 

PZN

PIP code

Packungsgroesse

Pack size

Packungseinheit

Unit of pack size

Packungscontainer

Container of pack size

Packungsbeschreibung

Description of pack size

Status

Status of the affected pack size. The following values are transmitted: not available, limited available, available according to §4 (1)*, available
Beginn_VertriebseinschraenkungBeginning of the shortage of the pack size
Datum_voraussichtliche_WiederbelieferungExpected supply of the pack size (if provided by the notifier)

Notification information -
Indication per pack size

 

Melder

Name of the notifying company

Datum_Meldung

Date of report

Datum_letzte_Aenderung

Last modification date

Mitteilung_Fachkreise

Information letter to healthcare professionals (yes/no)

Rechtsgrundlage_Meldung

Legal basis of the notification

Hinweis_BASG

Important BASG-information (optional)

Information of the medicinal product per pack size  

Zulassungsnummer

Marketing authorisation number

Bezeichnung_Arzneispezialitaet

Name of the medicinal product

Staerke

Strength

Darreichungsform

Dosage form

Parallelexportverbot

Parallelexport ban (yes/no)

Zulassungsinhaber

Marketing authorisation holder

Zulassungsinhaber_Tel

Telephone number of marketing authorisation holder

Grund

Reason of the shortage

Wirkstoffe

Active substances

Email

Further inquiry note